Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,023 across all filing types
Latest filing 2025-08-13 Transaction in Own Shar…
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from GSK plc regarding the purchase of its own shares (share buyback). It explicitly states 'Transaction in own shares' in the title and provides detailed trade data, including dates, prices, and volumes, which is characteristic of a share repurchase disclosure. This fits the definition of 'Transaction in Own Shares' (POS).
2025-08-13 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2025-08-12 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by Persons Discharging Managerial Responsibilities (PDMRs) at GSK plc. It explicitly lists the names, positions, and transaction details (acquisition of shares under a Share Reward Plan) for multiple executives. This aligns perfectly with the definition of 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2025-08-12 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-08-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from GSK plc regarding the purchase of its own shares (share buyback). It explicitly states 'Transaction in own shares' in the header and provides detailed trade data, including dates, prices, and trading venues, which is characteristic of a share repurchase disclosure. This fits the definition of the 'Transaction in Own Shares' (POS) category.
2025-08-12 English
FDA TO REVIEW GONORRHEA INDICATION FOR GEPOTIDACIN
Regulatory Filings
2025-08-11 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.